Literature DB >> 24771735

Aspergillus colonization in patients with bronchogenic carcinoma.

Sana Ali1, Abida Malik, Rakesh Bhargava, Mohammad Shahid, Nazish Fatima.   

Abstract

BACKGROUND: Aspergillus antigens such as galactomannan antigen, a cell wall polysaccharide, can be detected in patient's serum or bronchoalveolar lavage. To study the prevalence of Aspergillus infection in patients with bronchogenic carcinoma, we measured galactomannan antigen in serum and bronchoalveolar lavage samples of patients with bronchogenic carcinoma.
METHODS: The study was conducted on 45 bronchogenic carcinoma patients. The diagnosis of lung cancer was confirmed by bronchoscopy, histopathological and radiological examinations. Bronchoalveolar lavage fluid collected from each patient by fiberoptic bronchoscopy was subjected to direct microscopy and culture on Sabouraud's dextrose agar and Czapek-Dox agar, and Aspergillus galactomannan antigen was measured in serum and bronchoalveolar lavage samples.
RESULTS: The majority of patients were male (93.3%) in the age group 51-60 years, 88.9% were addicted to gutka chewing, and 82.1% were addicted to smoking. Most patients complained of cough (73%) and shortness of breath (51.1%). Squamous cell carcinoma (64.4%) was the most common malignancy, followed by adenocarcinoma (13.3%). On culture of bronchoalveolar lavage samples, 35.5% showed growth of Aspergillus spp. (Aspergillus fumigatus in 17.8%, Aspergillus flavus in 13.3%, and Aspergillus niger in 4.4%). Galactomannan antigen was detected in 58.3% of bronchoalveolar lavage samples and 47.2% of serum samples.
CONCLUSIONS: There is a high prevalence of aspergillosis in patients with lung carcinoma, especially among smokers and gutka chewers.

Entities:  

Keywords:  Aspergillus; Galactomannan; bronchogenic carcinoma

Mesh:

Substances:

Year:  2013        PMID: 24771735     DOI: 10.1177/0218492313513597

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  5 in total

1.  Lung cancer masquerading as fungus-associated mucoid impaction.

Authors:  Kohei Horiuchi; Takanori Asakura; Shinji Sakaguchi; Fumitake Saito
Journal:  BMJ Case Rep       Date:  2018-12-31

2.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

3.  Aspergillus niger bloodstream infection in gastric cancer after common hepatic artery embolization: A case report.

Authors:  Li Lin; Chuan-Hua Zhao; Xiu-Yun Yin; Yu-Ling Chen; Hong-Yan Zhai; Chun-Wei Xu; Yan Wang; Fei-Jiao Ge; Jian-Ming Xu
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

4.  Concurrent aspergillosis and cystic pulmonary metastases in a patient with tongue squamous cell carcinoma.

Authors:  Hung-Chieh Su; Che-Chi Liao; Chieh-Lung Chen; Wei Chih Liao; Wen-Chien Cheng
Journal:  Open Med (Wars)       Date:  2022-07-20

5.  Prevalence of invasive aspergillosis in suspected pulmonary tuberculosis at a referral tuberculosis hospital in Shandong, China.

Authors:  Jun-Li Wang; Xiao-Lin Zhou; Chao Han; Mao-Shui Wang; Hua Hu
Journal:  Epidemiol Infect       Date:  2020-11-05       Impact factor: 2.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.